Australian considerations for sustainable implementation of ultrasound guided procedures for difficult peripheral intravenous catheter insertion
Investigators: Professor Claire Rickard, Associate Professor Amanda Ullman, Dr Nicole Marsh, Ms Tricia Kleidon, Professor Gerben Keijzers, Ms Jessica Schults, Professor Marie Cooke, Associate Professor Joshua Byrnes, Professor Robert Ware, and Professor Louise CullenAssociate Investigators: Dr Catriona Booker, Dr Pauline Calleja, Dr Audra Gedmintas, Dr Henry Goldstein, Dr Stephanie Hadikusumo, Dr Krispin Hajkowicz, Dr Fiona Macfarlane, Associate Professor Steven McTaggart, Dr Nathan Peters, and Dr Stuart Watkins
Partner Organisations and Investigators: Children's Health Queensland Hospital and Health Service, Fiona Allsop; Gold Coast Hospital and Health Service, Dr Jeremy Wellwood; Australian Commission on Safety and Quality in Healthcare, Herbet Down; Queensland Health Aeromedical Retrieval and Disaster Management Branch, Dr Mark Elcock; Royal Brisbane and Women's Hospital (Queensland Health), Kerry McLeodThe use of ultrasound peripheral intravenous catheter (PIVC) insertion as the first approach for patients with difficult intravenous access is recommended in international guidelines. However, implementation of ultrasound PIVC insertion in Australia is negligible. This three-phased research project aims to address the use of ultrasound PIVC insertion in metropolitan, regional and remote Australian hospitals, and is led by researchers from Griffith University in partnership with the Australian Commission on Safety and Quality in Health Care, Queensland Health Department of Aeromedical Retrieval and Disaster Management Branch, Gold Coast University Hospital, Queensland Children's Hospital, and the Royal Brisbane and Women's Hospital.
Funded by a NHMRC Partnership Project Grant, this project will (1) collaborate with partners and stakeholders to co-design a DIVA Ultrasound Pathway and associated implementation strategies; (2) test our DIVA Ultrasound Pathway and strategies tested in the partner hospitals; and, (3) provide implementation tools to metropolitan, rural and remote settings.